Coronation Fund Managers Ltd. Atara Biotherapeutics, Inc. Transaction History

Coronation Fund Managers Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$5.69 - $17.78 $1.13 Million - $3.52 Million	-198,166 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$12.03 - $19.94 $1.28 Million - $2.12 Million	106,116 Added 115.28%	198,166 $2.8 Million
Q2 2019 Jul 25, 2019	BUY	$19.05 - $41.04 $1.11 Million - $2.4 Million	58,530 Added 174.61%	92,050 $1.85 Million
Q1 2019 Apr 24, 2019	BUY	$28.4 - $41.74 $951,968 - $1.4 Million	33,520 New	33,520 $1.33 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $776M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

Stay updated on Coronation Fund Managers Ltd. with notifications on news.